Lexaria Historical Balance Sheet

LEXXW Stock

USD 0.25 0.05 25.00%

Trend analysis of Lexaria Bioscience Corp balance sheet accounts such as Total Stockholder Equity of 9.7 M provides information on Lexaria Bioscience's total assets, liabilities, and equity, which is the actual value of Lexaria Bioscience Corp to its prevalent stockholders. By breaking down trends over time using Lexaria Bioscience balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Lexaria Bioscience Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lexaria Bioscience Corp is a good buy for the upcoming year.

Lexaria Bioscience Inventory

0.86

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

About Lexaria Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Lexaria Bioscience Corp at a specified time, usually calculated after every quarter, six months, or one year. Lexaria Bioscience Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Lexaria Bioscience and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Lexaria currently owns. An asset can also be divided into two categories, current and non-current.

Lexaria Bioscience Balance Sheet Chart

At this time, Lexaria Bioscience's Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 10.7 M in 2025, despite the fact that Net Debt is likely to grow to (5.4 M).

Other Current Liab Total Stockholder Equity Net Debt Accounts Payable

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Accounts Payable

An accounting item on the balance sheet that represents Lexaria Bioscience obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Lexaria Bioscience Corp are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Lexaria Bioscience's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Lexaria Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	239.9K	1.1M	1.2M	1.3M
Total Assets	3.1M	8.9M	10.2M	10.7M

Other Current Liab Total Assets

Lexaria Bioscience balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Short Long Term Debt Total	Current Deferred Revenue	Net Receivables	Short Term Debt	Inventory	Non Currrent Assets Other
Total Assets		0.6	0.35	0.99	0.01	-0.89	-0.71	0.64	0.96	0.2	0.96	0.57	0.24	0.31	0.71	0.81	0.28	0.21	0.96	-0.58	-0.23	-0.45	0.44	-0.23	-0.6	0.46
Other Current Liab	0.6		0.45	0.56	-0.2	-0.46	-0.7	0.98	0.58	0.0	0.55	0.55	0.41	0.55	0.94	0.8	0.35	0.02	0.61	-0.38	-0.29	0.12	0.01	-0.31	-0.56	0.8
Total Current Liabilities	0.35	0.45		0.21	0.77	0.08	-0.11	0.51	0.1	0.85	0.09	-0.2	0.29	0.38	0.33	0.2	0.97	0.86	0.11	-0.46	0.39	0.19	0.14	0.38	0.07	0.32
Total Stockholder Equity	0.99	0.56	0.21		-0.11	-0.94	-0.73	0.59	0.99	0.08	0.99	0.62	0.21	0.26	0.69	0.82	0.15	0.09	0.99	-0.55	-0.3	-0.51	0.43	-0.31	-0.64	0.43
Property Plant And Equipment Net	0.01	-0.2	0.77	-0.11		0.38	0.33	-0.1	-0.25	0.97	-0.24	-0.56	0.05	0.07	-0.28	-0.28	0.8	0.96	-0.26	-0.24	0.65	0.1	0.19	0.65	0.42	-0.18
Net Debt	-0.89	-0.46	0.08	-0.94	0.38		0.7	-0.46	-0.97	0.22	-0.98	-0.68	-0.12	-0.14	-0.61	-0.75	0.12	0.21	-0.97	0.41	0.43	0.52	-0.35	0.43	0.68	-0.39
Retained Earnings	-0.71	-0.7	-0.11	-0.73	0.33	0.7		-0.69	-0.72	0.11	-0.7	-0.86	-0.25	-0.63	-0.84	-0.97	-0.09	0.12	-0.75	0.34	0.57	0.44	-0.38	0.6	0.69	-0.4
Accounts Payable	0.64	0.98	0.51	0.59	-0.1	-0.46	-0.69		0.59	0.09	0.56	0.5	0.47	0.56	0.95	0.8	0.42	0.11	0.62	-0.45	-0.22	0.11	0.0	-0.24	-0.56	0.81
Cash	0.96	0.58	0.1	0.99	-0.25	-0.97	-0.72	0.59		-0.07	1.0	0.66	0.19	0.22	0.71	0.81	0.04	-0.05	1.0	-0.49	-0.36	-0.46	0.37	-0.36	-0.68	0.48
Non Current Assets Total	0.2	0.0	0.85	0.08	0.97	0.22	0.11	0.09	-0.07		-0.07	-0.37	0.13	0.21	-0.06	-0.05	0.85	1.0	-0.07	-0.35	0.56	0.02	0.28	0.56	0.26	-0.05
Cash And Short Term Investments	0.96	0.55	0.09	0.99	-0.24	-0.98	-0.7	0.56	1.0	-0.07		0.65	0.18	0.2	0.68	0.8	0.03	-0.05	1.0	-0.49	-0.36	-0.49	0.38	-0.36	-0.67	0.45
Common Stock Total Equity	0.57	0.55	-0.2	0.62	-0.56	-0.68	-0.86	0.5	0.66	-0.37	0.65		0.07	0.46	0.66	0.84	-0.25	-0.4	0.68	0.08	-0.77	-0.28	0.46	-0.8	-0.57	0.2
Common Stock Shares Outstanding	0.24	0.41	0.29	0.21	0.05	-0.12	-0.25	0.47	0.19	0.13	0.18	0.07		0.23	0.45	0.31	0.24	0.15	0.21	-0.35	-0.19	0.04	-0.3	-0.18	-0.01	0.28
Non Current Liabilities Total	0.31	0.55	0.38	0.26	0.07	-0.14	-0.63	0.56	0.22	0.21	0.2	0.46	0.23		0.53	0.59	0.41	0.2	0.25	-0.12	-0.26	-0.07	0.28	-0.31	-0.3	0.22
Other Current Assets	0.71	0.94	0.33	0.69	-0.28	-0.61	-0.84	0.95	0.71	-0.06	0.68	0.66	0.45	0.53		0.91	0.23	-0.04	0.74	-0.49	-0.4	-0.13	0.05	-0.41	-0.67	0.73
Other Stockholder Equity	0.81	0.8	0.2	0.82	-0.28	-0.75	-0.97	0.8	0.81	-0.05	0.8	0.84	0.31	0.59	0.91		0.13	-0.05	0.84	-0.41	-0.51	-0.38	0.35	-0.53	-0.71	0.52
Total Liab	0.28	0.35	0.97	0.15	0.8	0.12	-0.09	0.42	0.04	0.85	0.03	-0.25	0.24	0.41	0.23	0.13		0.86	0.05	-0.43	0.41	0.16	0.17	0.4	0.11	0.23
Property Plant And Equipment Gross	0.21	0.02	0.86	0.09	0.96	0.21	0.12	0.11	-0.05	1.0	-0.05	-0.4	0.15	0.2	-0.04	-0.05	0.86		-0.06	-0.42	0.58	-0.01	0.22	0.58	0.23	-0.02
Total Current Assets	0.96	0.61	0.11	0.99	-0.26	-0.97	-0.75	0.62	1.0	-0.07	1.0	0.68	0.21	0.25	0.74	0.84	0.05	-0.06		-0.49	-0.39	-0.46	0.38	-0.39	-0.69	0.48
Common Stock	-0.58	-0.38	-0.46	-0.55	-0.24	0.41	0.34	-0.45	-0.49	-0.35	-0.49	0.08	-0.35	-0.12	-0.49	-0.41	-0.43	-0.42	-0.49		-0.26	0.55	0.14	-0.28	0.48	-0.47
Short Long Term Debt Total	-0.23	-0.29	0.39	-0.3	0.65	0.43	0.57	-0.22	-0.36	0.56	-0.36	-0.77	-0.19	-0.26	-0.4	-0.51	0.41	0.58	-0.39	-0.26		0.21	-0.18	1.0	0.09	0.17
Current Deferred Revenue	-0.45	0.12	0.19	-0.51	0.1	0.52	0.44	0.11	-0.46	0.02	-0.49	-0.28	0.04	-0.07	-0.13	-0.38	0.16	-0.01	-0.46	0.55	0.21		-0.25	0.18	0.43	0.2
Net Receivables	0.44	0.01	0.14	0.43	0.19	-0.35	-0.38	0.0	0.37	0.28	0.38	0.46	-0.3	0.28	0.05	0.35	0.17	0.22	0.38	0.14	-0.18	-0.25		-0.2	-0.06	-0.22
Short Term Debt	-0.23	-0.31	0.38	-0.31	0.65	0.43	0.6	-0.24	-0.36	0.56	-0.36	-0.8	-0.18	-0.31	-0.41	-0.53	0.4	0.58	-0.39	-0.28	1.0	0.18	-0.2		0.12	0.15
Inventory	-0.6	-0.56	0.07	-0.64	0.42	0.68	0.69	-0.56	-0.68	0.26	-0.67	-0.57	-0.01	-0.3	-0.67	-0.71	0.11	0.23	-0.69	0.48	0.09	0.43	-0.06	0.12		-0.68
Non Currrent Assets Other	0.46	0.8	0.32	0.43	-0.18	-0.39	-0.4	0.81	0.48	-0.05	0.45	0.2	0.28	0.22	0.73	0.52	0.23	-0.02	0.48	-0.47	0.17	0.2	-0.22	0.15	-0.68

Click cells to compare fundamentals

Lexaria Bioscience Account Relationship Matchups

Lexaria Bioscience balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	13.3M	7.8M	3.1M	8.9M	10.2M	10.7M
Other Current Liab	45K	51.7K	239.9K	1.1M	1.2M	1.3M
Total Current Liabilities	153.3K	194.0K	267.7K	1.1M	989.5K	1.0M
Total Stockholder Equity	13.3M	7.9M	3.0M	8.0M	9.2M	9.7M
Property Plant And Equipment Net	459.3K	367.9K	421.6K	389.6K	350.6K	333.1K
Net Debt	(10.8M)	(5.8M)	(1.2M)	(6.4M)	(5.7M)	(5.4M)
Retained Earnings	(31.8M)	(39.1M)	(45.8M)	(51.6M)	(46.4M)	(44.1M)
Accounts Payable	59.9K	25.8K	225.0K	1.1M	1.2M	1.3M
Cash	10.9M	5.8M	1.4M	6.5M	7.5M	7.8M
Non Current Assets Total	823.9K	856.4K	884.2K	969.8K	872.8K	1.3M
Cash And Short Term Investments	11.8M	6.2M	1.5M	6.6M	7.5M	7.9M
Common Stock Shares Outstanding	4.4M	5.9M	6.6M	12.4M	14.2M	15.0M
Liabilities And Stockholders Equity	13.3M	7.8M	3.1M	8.9M	10.2M	10.7M
Non Current Liabilities Total	50.0K	7.4K	136.2K	109.3K	98.4K	93.5K
Other Current Assets	319.3K	576.8K	546.8K	1.2M	1.4M	1.4M
Other Stockholder Equity	45.1M	47.0M	48.8M	59.6M	68.6M	72.0M
Total Liab	203.3K	201.4K	403.9K	1.2M	1.1M	577.9K
Property Plant And Equipment Gross	773.2K	747.9K	896.8K	907.2K	816.5K	1.3M
Total Current Assets	12.4M	7.0M	2.2M	7.9M	9.1M	9.5M
Common Stock	90.0K	5.7K	6.0K	8.1K	9.3K	8.8K
Short Long Term Debt Total	97.3K	50.0K	164.0K	137.4K	123.6K	117.4K
Net Receivables	342.4K	201.8K	175.2K	154.5K	177.6K	166.2K
Short Term Debt	47.3K	85.2K	27.8K	28.0K	25.2K	24.0K
Inventory	116.9K	29.6K	38.4K	1.0	0.9	0.86
Non Currrent Assets Other	(823.9K)	(856.4K)	(884.2K)	63.6K	73.1K	76.8K
Intangible Assets	364.6K	488.5K	462.6K	516.7K	594.2K	623.9K
Net Invested Capital	13.3M	7.9M	3.0M	8.0M	9.2M	5.9M
Net Working Capital	12.3M	6.8M	1.9M	6.8M	7.8M	5.0M
Short Term Investments	833.8K	347.3K	125.6K	55.8K	64.2K	61.0K
Capital Stock	5.7K	6.0K	8.1K	15.8K	14.2K	13.5K
Capital Lease Obligations	89.4K	50.0K	164.0K	137.4K	158.0K	124.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lexaria Historical Balance Sheet

Lexaria Bioscience Inventory

0.86

About Lexaria Balance Sheet Analysis

Lexaria Bioscience Balance Sheet Chart

Total Stockholder Equity

Net Debt

Accounts Payable

Lexaria Bioscience balance sheet Correlations

Lexaria Bioscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Lexaria Bioscience balance sheet Accounts

Also Currently Popular

Additional Tools for Lexaria Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Property Plant And Equipment Gross	+ 1.0	Non Current Assets Total
Total Current Assets	+ 1.0	Cash And Short Term Investments
Short Term Debt	+ 1.0	Short Long Term Debt Total
Total Stockholder Equity	+ 0.99	Total Assets

Cash And Short Term Investments	- 0.98	Net Debt
Other Stockholder Equity	- 0.97	Retained Earnings
Total Current Assets	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Net Debt	- 0.94	Total Stockholder Equity
Net Debt	- 0.89	Total Assets